DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kieffer T, Sarrazin C, Miller J. et al.
Combination of telaprevir (VX-950) and PEG-IFN-alfa suppressed both wild-type virus and resistance variants in HCV genotype 1-infected patients in a 14-day phase 1B study
Hepatology 2006; 44: 222A-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.